加拿大曼尼托巴省骨折后诊疗的人群研究:2000/2001至2014/2015
该研究基于加拿大曼尼托巴省人群健康行政数据,纳入50岁以上发生主要骨质疏松性骨折者18541例及无骨折对照92705例(按年龄、性别、居住区5:1匹配),评估全省骨折后通知项目对骨折后诊疗的持续改善作用及相关因素。结果显示骨折病例接受DXA检测和/或骨质疏松药物治疗的比例上升(p<0.001),而对照下降(p<0.001);通知项目实施后年份的骨质疏松诊疗比值比约为临床试验前年份的两倍。结论认为采用人群骨折后通知项目带来了骨折后诊疗的持续改善。
要点
- 骨折病例接受DXA检测和/或骨质疏松药物的比例上升(p<0.001),对照下降(p<0.001)。
- 通知项目实施后年份的骨质疏松诊疗比值比约为临床试验前年份的两倍。
- 既往主要骨质疏松性骨折与接受骨质疏松诊疗相关(OR 9.03,95%CI 8.60-9.48)。
核心结论
- 采用人群骨折后通知项目带来了骨折后诊疗的持续改善。
研究设计与样本
- 回顾性匹配队列研究,使用加拿大曼尼托巴省人群健康行政数据。
- 纳入50岁以上发生主要骨质疏松性骨折者18541例,以及按年龄、性别、居住区5:1匹配的无骨折对照92705例。
- 采用Cochran-Armitage检验分析骨折病例与对照的骨质疏松诊疗结局线性趋势,采用逻辑回归检验与接受骨质疏松诊疗可能性相关的特征。
主要发现
- 骨折病例接受DXA检测和/或骨质疏松药物治疗的比例上升(p<0.001),而对照下降(p<0.001)。
- 通知项目实施后年份的骨质疏松诊疗比值比约为临床试验前年份的两倍。
- 与接受骨质疏松诊疗相关的因素包括既往主要骨质疏松性骨折(OR 9.03,95%CI 8.60-9.48)、较低收入(OR 0.72,95%CI 0.67-0.78)、糖皮质激素使用(OR 4.37,95%CI 3.72-5.14)、糖尿病诊断(OR 0.74,95%CI 0.68-0.80)及Charlson合并症指数(1-2分:OR 1.27,95%CI 1.20-1.34;3-5分:OR 1.26,95%CI 1.13-1.40)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: We previously found that population-based postfracture notification, which informed primary care physicians of their patient's recent fracture and suggested assessment for osteoporosis, led to an improvement in postfracture care in the context of a randomized controlled trial ( ClinicalTrials.gov identifier NCT00594789, fractures from late 2007 to mid-2010). Since June 2010, a province-wide postfracture notification program was implemented. This study was to (1) determine whether this program has resulted in sustained improvement in postfracture care and (2) test factors associated with receiving osteoporosis care. METHODS: A retrospective matched cohort study was performed using population-based health administrative data in Manitoba, Canada. We selected individuals aged 50+ years with an incident major osteoporosis fracture (MOF; N = 18,541) in fiscal years 2000/2001 to 2013/2014 and controls without a MOF (N = 92,705) matched (5:1) on age, sex, and residential area. The Cochran-Armitage test tested for a linear trend in osteoporosis care outcomes for cases and controls. Logistic regressions were used to test characteristics associated with the likelihood of receiving osteoporosis care. RESULTS: The percentage of individuals receiving DXA testing and/or osteoporosis medication increased in fracture cases (p < 0.001), but decreased in controls (p < 0.001). Odds ratios for osteoporosis care in years following the postfracture notification program were approximately double of those prior to the clinical trial. In addition to prior MOF (OR 9.03, 95% CI 8.60-9.48), factors associated with osteoporosis care included lower income (OR 0.72, 95% CI 0.67-0.78), glucocorticoid use (OR 4.37, 95% CI 3.72-5.14), diabetes diagnosis (OR = 0.74, 95% CI 0.68-0.80), and Charlson Comorbidity Index (indexes 1-2: OR 1.27, 95% CI 1.20-1.34; indexes 3-5: OR 1.26, 95% CI 1.13-1.40). CONCLUSIONS: Adopting a population-based postfracture notification program led to sustained improvements in postfracture care.
引用
- Cui Y, Lix LM, Yang S, et al. A population-based study of postfracture care in Manitoba, Canada 2000/2001-2014/2015. Osteoporos Int. 2019. PMID: 31267162. doi:10.1007/s00198-019-05074-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。